Stocktoria

ALX ONCOLOGY HOLDINGS INC ALXO

Nasdaq · stock · Pharmaceutical Preparations · website · IPO 2020-07-17

ALX ONCOLOGY HOLDINGS INC statistics & valuation

Market cap$274.5M
P / B10.6×
Net cash$6.2M
Enterprise value USD$268.3M
Earnings yield EBIT/EV-38.8%
Return on capital-301.6%

Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else from the latest financial reports.

Profitability & efficiency

Gross margin (%)
2019202020212022202320242025
Operating margin (%)
-400.00% -3694.00% 2019202020212022202320242025
Return on equity (%)
-10.60% -23.00% -46.90% -84.80% -118.70% -391.40% 2019202020212022202320242025
Shares outstanding
3.2M 39.8M 40.6M 40.9M 50.0M 53.1M 54.4M 2019202020212022202320242025
Net debt ($)
-$3.6M -$38.2M -$11.8M -$7.0M -$6.2M 2019202020212022202320242025
Share buybacks ($)
2019202020212022202320242025
Return on assets (%)
-180.20% -10.50% -22.00% -40.30% -66.30% -91.30% -172.20% 2019202020212022202320242025
Free cash flow margin (%)
-304.50% -3242.00% 2019202020212022202320242025
Debt / equity (×)
0.04× 0.06× 0.09× 0.39× 2019202020212022202320242025
EPS ($)
-$2.76 -$2.07 -$3.03 -$3.74 -$2.58 -$1.90 2019202020212022202320242025

Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).

Key ratios (by fiscal year)

RatioFY2025FY2024FY2023FY2022FY2021FY2020FY2019
Operating margin—————-3694.0%-400.0%
Net margin—————-3869.7%-401.2%
FCF margin—————-3242.0%-304.5%
Return on assets-172.2%-91.3%-66.3%-40.3%-22.0%-10.5%-180.2%
Return on equity-391.4%-118.7%-84.8%-46.9%-23.0%-10.6%27.2%
Debt / equity0.39×0.09×0.06×0.04×——-0.08×
Current ratio2.077.265.249.5724.0070.281.97

Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.